Rapid leukaemic evolution in a cutaneous blastic NK-cell lymphoma initially diagnosed as pseudolymphoma.
Di Mario
Antonella
A
Istituto di Ematologia, Università Cattolica del Sacro Cuore, Rome, Italy.
Garzia
Mariagrazia
M
d'Alò
Francesco
F
Rumi
Carlo
C
Massini
Giuseppina
G
Bellesi
Silvia
S
Zini
Gina
G
D000368:Aged; D015703:Antigens, CD / Q000032:analysis; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage / Q000627:therapeutic use; D014408:Biomarkers, Tumor; D001761:Bleomycin / Q000008:administration & dosage; D015704:CD4 Antigens / Q000032:analysis; D019002:CD56 Antigen / Q000032:analysis; D003520:Cyclophosphamide / Q000008:administration & dosage; D003937:Diagnosis, Differential; D003951:Diagnostic Errors; D018450:Disease Progression; D004317:Doxorubicin / Q000008:administration & dosage; D006684:HLA-DR Antigens / Q000032:analysis; D006801:Humans; D007694:Killer Cells, Natural / Q000473:pathology*; D008198:Lymph Nodes / Q000000981:diagnostic imaging; D008228:Lymphoma, Non-Hodgkin / Q000737:chemistry / Q000175:diagnosis* / Q000188:drug therapy / Q000473:pathology; D016410:Lymphoma, T-Cell, Cutaneous / Q000175:diagnosis; D008297:Male; D009363:Neoplasm Proteins / Q000032:analysis; D011241:Prednisone / Q000008:administration & dosage; D019253:Proto-Oncogene Proteins c-bcl-2 / Q000032:analysis; D019310:Pseudolymphoma / Q000175:diagnosis*; D011859:Radiography; D012878:Skin Neoplasms / Q000737:chemistry / Q000175:diagnosis* / Q000188:drug therapy; D014750:Vincristine / Q000008:administration & dosage
D015703:Antigens, CD; D014408:Biomarkers, Tumor; D015704:CD4 Antigens; D019002:CD56 Antigen; D006684:HLA-DR Antigens; D009363:Neoplasm Proteins; D019253:Proto-Oncogene Proteins c-bcl-2; D001761:Bleomycin; D014750:Vincristine; D004317:Doxorubicin; D003520:Cyclophosphamide; D011241:Prednisone